MEA Home Healthcare Market (By Type: Device, Services; By Device: Diagnostic & Monitoring Devices, Therapeutic Devices, Home Mobility Assist Devices; By Services: Rehabilitation, Telehealth, Respiratory Therapy, Infusion Therapy, Unskilled Homecare) Industry Size, Share, Growth, Trends 2026 to 2035.
The MEA home healthcare market reached USD 21.94 M in 2025 and is set to hit USD 76.10 M by 2035 at a 13.24% CAGR. Growth is driven by rising chronic illnesses, aging populations, and the shift toward affordable in-home care.
| Reports Attributes | Statistics |
| Market Size in 2025 | USD 21.94 Million |
| Market Size in 2026 | USD 24.91 Million |
| Market Size in 2032 | USD 53.24 Million |
| Market Size by 2035 | USD 76.10 Million |
| CAGR 2026 to 2035 | 13.24% |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
The Middle East and Africa home healthcare market is expanding at a rapid pace due to the rapid demographic shifts in the region, where elderly people are increasing, with an increasing number of chronic conditions like diabetes, asthma, COPD, and many more. As a result, the government is focused on implementing home healthcare services to provide a low-cost alternative for patients over a longer period. The rapid growth in healthcare infrastructure is also driving partnership opportunities for organizations to collaborate with home-based service providers and generate significant revenue by providing post-acute care. Additionally, governments are prioritizing local providers and manufacturers for these services and production, thereby building a stronger foundation for emerging countries.
Home healthcare services are expanding rapidly in the urban areas of the MEA region. However, some countries still lack standardization for these services, which can affect trust and reliability. The limited urban influence also faces challenges due to labor shortages in home care and other administrative tasks. Additionally, lower insurance awareness in the Middle East and African countries makes most healthcare services expensive and may require patients to pay out-of-pocket.
The increasing prevalence of chronic illness in South African countries is expected to drive a major focus by the government on promoting remote healthcare monitoring. The number of chronic care services is increasing, with RPM devices, teleconsults, and other chronic care services being covered in GCC countries. The healthcare companies in the region are investing heavily in partnerships to provide more services to patients through tenders and grant systems for service providers. Additionally, the core focus on improving the local workforce is expected to help create more skilled nurses and therapists. The emergence of app-based healthcare is expected to simplify administrative tasks for both parties.
The use of technologies like artificial intelligence (AI) is becoming increasingly popular in the overall healthcare sector due to its application in RPM signals and SDOH proxies that help with risk stratification, which can have a huge impact on remote monitoring modules. These technologies are highly reliant on digital penetration, guiding workforces in remote settings to follow protocols and ensure patient safety. The growing urbanization in the region will help in using AI for quality monitoring through the providers that detect safety signals and ensure a safe, successful home-based healthcare.
Saudi Arabia stands as one of the leading countries in the Middle East and Africa home healthcare market due to the increasing government investments towards healthcare infrastructure. Many digital health initiatives, such as the 937 call center, e-health services, and Sehhaty mobile applications for virtual consultations, are expected to drive more people to opt for home healthcare services in the country. The country is witnessing a higher number of chronic illnesses like diabetes, obesity, and many more, which is creating a huge demand for home nursing.
The United Arab Emirates stands as one of the most opportunistic countries in the Middle East and Africa markets due to the increasing investment in healthcare, particularly in DME and other consumables. Rapid urbanization and rising disposable incomes are also driving growth through private healthcare expansion. Moreover, citizens are increasingly adopting healthcare insurance in the area, making home healthcare more accessible and cost-effective for them in the long run.
| Regions | Shares (%) |
| Simple Generics | 47.18% |
| Super Generics | 52.82% |
| Segments | Shares (%) |
| Pure Generic Drugs | 42.64% |
| Branded Generic Drugs | 57.36% |
| Segments | Shares (%) |
| Oral | 25.39% |
| Injection | 28.44% |
| Cutaneous | 22.15% |
| Others | 24.02% |
| Segments | Shares (%) |
| Central Nervous System (CNS) | 16.53% |
| Cardiovascular | 12.88% |
| Infectious Diseases | 13.72% |
| Musculoskeletal Diseases | 14.96% |
| Respiratory | 14.20% |
| Oncology | 14.57% |
| Others | 13.14% |
| Segments | Shares (%) |
| Retail Pharmacy | 36.02% |
| Hospital Pharmacy | 34.58% |
| Online and Others | 29.40% |
Published by Ajit Bansod
